losidar 50 mg filmom obložene tablete
mylan hrvatska d.o.o., koranska 2, zagreb - losartanum - filmom obložena tableta - 50 mg - urbroj: svaka filmom obložena tableta sadrži 50 mg losartankalija
složena otopina natrijevog laktata, otopina za infuziju (hartmannova otopina)
b. braun adria d.o.o., hondlova 2/9, zagreb - natrijev klorid kalijev klorid kalcijev klorid dihidrat natrijev laktat, otopina - otopina za infuziju - 6,0 g + 0,40 g + 0,27 g + 6,24 g - urbroj: 1000 ml otopine sadrži 6,0 g natrijevog klorida, 0,40 g kalijevog klorida, 0,27 g kalcijevog klorida dihidrata i 6,24 g natrijevog laktata, otopine
cosopt pf 20 mg/ml + 5 mg/ml kapi za oko, otopina u jednodoznom spremniku
santen oy, niittyhaankatu 20, tampere, finska - dorzolamidklorid timololmaleat - kapi za oko, otopina u jednodoznom spremniku - 20 mg/ml + 5 mg/ml - urbroj: 1 ml sadrži 20 mg dorzolamida u obliku dorzolamidklorida i 5 mg timolola u obliku timololmaleata
tienam 500 mg/500 mg prašak za otopinu za infuziju
merck sharp & dohme d.o.o., ivana lučića 2a, zagreb - imipenemum, cilastatinum - prašak za otopinu za infuziju - 500 mg/500 mg - urbroj: jedna bočica sadrži imipenem hidrat što odgovara 500 mg imipenema bezvodnog i cilastatinnatrij što odgovara 500 mg cilastatina
stat-gel fs ferric sulfate gel
vik-dental d.o.o. vladimira preloga 13 10000 zagreb -
zotramid 75 mg/650 mg tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - tramadolklorid paracetamol - tableta - 75 mg + 650 mg - urbroj: jedna tableta sadrži 75 mg tramadolklorida i 650 mg paracetamola
dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti za dermatitis, isključujući kortikosteroide - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
amphotericin b bharat 50 mg/1 bočica prašak za rastvor za infuziju
rhei life d.o.o. bijeljina - amfotericin b - prašak za rastvor za infuziju - 50 mg/1 bočica - 1 bočica sadrži: 50 mg lipozomalnog amfotericina b
palynziq
biomarin international limited - pegvaliase - phenylketonurias - ostali prehrambeni proizvodi i proizvodi metabolizma - palynziq indiciran za liječenje bolesnika s fenilketonurija (pku) u dobi od 16 godina i stariji, koji imaju neprimjeren kontrolu fenilalanin u krvi (nivo fenilalanin u krvi više od 600 мкмоль/l), bez obzira na do upravljanja dostupne mogućnosti liječenja .
chondrocelect
tigenix n.v. - karakterizirane održive autologne stanice hrskavice eksprimiraju ex vivo eksprimirajući specifične markere proteine - bolesti hrskavice - ostali lijekovi za poremećaje mišićno-koštanog sustava - popravak oštećenja jednog simptomatsko hrskavice kondila bedrene koljena (international hrskavice repair society [icrs] stupnja iii ili iv) u odraslih. polaznik asimptomatskih lezija hrskavice (ПВК klase i ili ii) mogu biti prisutni. demonstracija efikasnosti temelji se na randomizirana kontrolirana studija o proceni efikasnosti chondrocelect u bolesnika s porazom od 1 do 5 cm2.